Even though sales of non-alcoholic beer have risen substantially in Denmark and Europe in the last couple of years, there are still many people that won’t follow the healthy trend because they find the taste not to be quite as good as that of regular beers.
InSphero AG, the pioneer in 3D cell-based assay and organ-on-chip technology, today announced the strengthening of its Scientific Advisory Board (SAB) with the appointment of Professor Nikolai Naoumov, MD PhD.
Researchers at the University of Washington have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests that are processed in medical labs and hospitals.
Scientists at the University of Bristol have developed new biological parts that are able to shape the flow of cellular processes along DNA.
Many pharmaceutically relevant marine sponges are found only in trace amounts within the source sponge, and it is neither economically nor ecologically feasible to harvest enough wild sponge biomass to supply the necessary quantities for clinical drug development and manufacture. Researchers have come up with a viable solution – develop sponge cell lines for rapid division and successfully culture them in 3D to scale-up production.
-rgb300-(1)-for-web-page.jpg&width=400&height=400)
A patented biomaterial developed by South Dakota State University associate professor Gudiseva Chandrasekher has the potential to repair corneal damage and to create corneal implants.
UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.
A new Cornell University-led project will accelerate the application of a proven biotechnology to enhance food and nutritional security in Bangladesh and the Philippines while protecting the health of farmers and the environment.
Together with colleagues from the Institute of Biomedical Chemistry, biologists from the Research Center of Biotechnology RAS have studied a new L-asparaginase from hyperthermophilic archaea Thermococcus sibiricus. These archaea live at a depth of more than two thousand meters in a high-temperature oil reservoir in Siberia. This biotechnologically important enzyme is used in the food industry, in the development of biosensors, and in medicine due to its antitumor activity. L-asparaginase from T. sibiricus was described for the first time by the authors of this research. This enzyme differs from the previously described analogs by its increased stability and selective toxicity to cancer cells.
Biofabrication company to advance key tissue applications
Research led by the University of Alabama in Huntsville (UAH) has for the first time identified the precise genetic operational structure of a key system in Escherichia coli (E. coli) bacteria, opening the door to possible new antibiotics to treat the infections it causes.
In Applied Physics Reviews, researchers review scientific advances of electrolyte-gated carbon nanotube field-effect transistor biosensors, which are characterized by superior electronic properties and intrinsic signal amplification and are capable of detecting a wide range of biomolecules with high sensitivity. One of their main components is the biorecognition element, which selectively recognizes the analyte of interest. Biotransduction devices convert the interaction between the biorecognition element and analyte into a measurable signal.
Hertz Fellows Judy Savitskaya, Katie Bodner Spielberg, and Kelly Moynihan transitioned to biotech venture capital after receiving their PhDs in bioengineering, enabling them to work closely with forward-thinking entrepreneurs and promising new biotechnologies.
Alloplex Biotherapeutics and Hackensack Meridian Health announce Equity Investment
Detecting the activity of CRISPR gene editing tools in organisms with the naked eye and an ultraviolet flashlight is now possible using technology developed at the Department of Energy’s Oak Ridge National Laboratory.
In APL Bioengineering, researchers have developed an approach to print skin equivalents, which may play a future role in facilitating the healing of chronic wounds. They used suspended layer additive manufacturing, creating a gel-like material to support the skin equivalent that can then support a second phase of gel injection. During printing, the skin layers are deposited within the support gel. After printing, the team washed away the support material, leaving behind the layered skin equivalent.
Just as convincing images of cats can be created using artificial intelligence, new proteins can now be made using similar tools.
Researchers have made significant advances toward the goal of a new microchip able to grow DNA strands that could provide high-density 3D archival data storage at ultra-low cost – and be able to hold that information for hundreds of years.
A novel medical device that works as an absorbable implant for meniscal reconstruction, invented by researchers at Rutgers, The State University of New Jersey, received the 2021 Thomas Edison Patent Award in the Biotechnology category. The tissue-engineered implant treats meniscal tears to lessen or even entirely rid the need for a total knee replacement surgery. The implant also recreates the anatomy and fiber geometry of the meniscus.
A new laboratory will bring researchers from South Dakota State University and South Dakota Mines together with industry partners to transition bench-scale bioprocessing and bioproducts research to the marketplace.
After a spell of unexpected rain, before the harvest season, a farmer may be faced with the unpredictable problem of untimely sprouting of barley.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
In research published in Langmuir, a team led by Steven Cramer, an endowed chair professor of chemical and biological engineering at Rensselaer Polytechnic Institute, explored the fundamentals of how different molecules interact with various surfaces during the purification process.
According to the latest Association of University Technology Managers (AUTM) North American Annual Licensing Survey, the University Health Network (UHN) ranks as the #1 research commercialization institution in Canada for the second year running according to gross licensing revenue from the research it has commercialized.
Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells.
New Berkeley Lab breakthroughs: engineering chemical-producing microbes; watching enzyme reactions in real time; capturing the first image of ‘electron ice’; revealing how skyrmions really move
With the signing of a statement of cooperation, the BioProducts Institute at the University of British Columbia (BPI) and Empa are celebrating a new partnership to promote innovation and collaboration, furthering joint developments in the field of biobased solutions.
Researchers led by Iowa State's Laura Jarboe are working to improve bioproduction of fuels and chemicals by finding enzymes that can withstand the heat and acidity used to lower industrial fermentation costs. The project is supported by a three-year, $969,000 grant from the U.S. Department of Energy.
The reconstituted biological clock maintains daily cycles for days on end, allowing researchers to study the interactions of its component parts
The Donald Danforth Plant Science Center has signed a Memorandum of Understanding (MoU) with the National Agricultural Seeds Council (NASC) in Abuja, Nigeria, for cooperation in seed certification molecular technologies and support to the national biotechnology strategy.
Scientists have figured out how plants respond to light and can flip this genetic switch to encourage food growth.
Researchers at the Centre for Genomic Regulation (CRG) and Pulmobiotics S.L have created the first ‘living medicine’ to treat antibiotic-resistant bacteria growing on the surfaces of medical implants.
The Integrated Biochemical and Electrochemical Technologies to Convert Organic Waste to Biopower collaboration has a workforce component that will bring new technologies and new talent from the United States, Canada and Mexico to the bioenergy industry.
In APL Materials, researchers have developed a bioelectrical sensor that is convenient and low-cost. The sensor measures electromyography signals that are generated in muscles when they contract and are useful for studying muscle fatigue and recovery, and they have the potential to inform diagnosis and treatment of neuromuscular diseases. The biosensor, made of silver paste with a layer of gold nanoparticles on top, is directly integrated onto a piece of clothing. The result was a detector that was both conductive and nonirritating to the skin.
Scientists at Sandia National Laboratories and their collaborators have developed a new membrane, whose structure was inspired by a protein from algae, for electrodialysis that could be used to provide fresh water for farming and energy production.
A variety of scientific discovery and technology awards were presented during SLAS Europe 2021 Digital Conference and Exhibition, which took place June 23-25 online. The annual European forum of the Society for Laboratory Automation and Screening bestowed the Ignite Award to the most promising new startup company, the New Product Award, SLAS Tony B. Academic Awards and Student Poster Awards.
Omega Bio-tek, a leading nucleic acid purification kit manufacturer, releases an automation-ready, prefilled DNA extraction kit for magnetic processors to purify DNA faster and easier than before. The convenient Mag-Bind® Blood & Tissue DNA HDQ Prefilled 96 Kit comes prefilled with magnetic beads, reagent plates, and tip combs and aims to simplify setup and processing time for magnetic processors such as the Thermo Fisher Scientific KingFisher™ Flex, Qiagen BioSprint®, and the Applied Biosystems MagMax® Express-96.
Fapon Biotech, a mainstream COVID-19 raw materials supplier to the global top-profile reagent manufacturers, introduced pioneering COVID-19 antibodies for antigen lateral flow testing to detect and differentiate COVID-19 and the most notable variant B.1.1.7 (also known as SARS-CoV-2 VUI 202012/01) in human samples.
The future of vaccines may look more like eating a salad than getting a shot in the arm.
A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.
BioIVT’s ASTERAND® Human Tissue Repository contains clinical data from more than one million biospecimens and can be mined to reveal patterns and relationships in disease etiology and pathology.
A new study from the University of Surrey has revealed that biotechnology could be the missing ingredient in helping cocoa farmers get a better deal for their beans.
Cleveland Clinic researchers have engineered a first-of-its-kind bionic arm for patients with upper-limb amputations that allows wearers to think, behave and function like a person without an amputation, according to new findings published in Science Robotics.
In recent years, scientists have developed monoclonal antibodies — proteins that mimic the body’s own immune defenses — that can combat a variety of diseases, including some cancers and autoimmune disorders such as Crohn’s disease.
Biologists at Sandia National Laboratories developed comprehensive software that will help scientists in a variety of industries create engineered chemicals more quickly and easily. Sandia is now looking to license the software for commercial use, researchers said.
طوّر باحثو مايو كلينك وزملاؤهم في معهد ماساتشوستس للتكنولوجيا (MIT) معجونًا سريع الالتصاق يمكنه إيقاف نزيف الأعضاء بشكل مستقل دون تخثر. التفاصيل منشورة في مجلة الهندسة الطبية الحيوية لنيتشر.
Pesquisadores da Mayo Clinic e colegas do Instituto de Tecnologia de Massachusetts (Massachusetts Institute of Technology, MIT) desenvolveram uma cola de selagem rápida que pode estancar o sangramento de órgãos independentemente da coagulação.
妙佑医疗国际(Mayo Clinic) 的研究人员与麻省理工学院(MIT)的同事们合力研发出了一种快速密封胶，可以在不依赖凝血的情况下快速阻止器官出血。其详细介绍已发表在《自然生物医学工程》(Nature Biomedical Engineering)上。
Los investigadores de Mayo Clinic y sus colegas del Instituto Tecnológico de Massachusetts (MIT, por sus siglas en inglés) elaboraron un pegamento que sella rápido y es capaz de detener el sangrado en los órganos, independientemente de la coagulación.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
